title: Additive effects of another kind of HMG-CoA reductase inhibitor with different pharmacokinetics in the treatment of heterozygous familial hypercholesterolemia.
authors.forename: T
authors.initials: T
authors.lastname: Nozue
authors.forename: A
authors.initials: A
authors.lastname: Nohara
authors.forename: T
authors.initials: T
authors.lastname: Higashikata
authors.forename: A
authors.initials: A
authors.lastname: Inazu
authors.forename: H
authors.initials: H
authors.lastname: Mabuchi
authors.forename: K
authors.initials: K
authors.lastname: Kajinami
authors.forename: J
authors.initials: J
authors.lastname: Koizumi
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006579:Heterozygote; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors